129 related articles for article (PubMed ID: 2576023)
1. Effects of some antipsychotic drugs on cardiovascular catecholamine receptors in the rat.
Cuffí ML; Vila E; Badia A
J Auton Pharmacol; 1989 Dec; 9(6):397-409. PubMed ID: 2576023
[TBL] [Abstract][Full Text] [Related]
2. Effects of bromocriptine on catecholamine receptors mediating cardiovascular responses in the pithed rat.
Vila E; Badia A; Jane F
J Auton Pharmacol; 1985 Jun; 5(2):125-30. PubMed ID: 2991290
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory dopamine receptors on sympathetic neurons innervating the cardiovascular system of the pithed rat. Characterization and role in relation to presynaptic alpha 2-adrenoceptors.
Wilffert B; Smit G; de Jonge A; Thoolen MJ; Timmermans PB; van Zwieten PA
Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun; 326(2):91-8. PubMed ID: 6089003
[TBL] [Abstract][Full Text] [Related]
4. Increased peripheral alpha 1-adrenoceptor sensitivity following chronic thioridazine treatment in the pithed rat.
Cuffí ML; Vila E; Badia A
Eur J Pharmacol; 1989 Sep; 168(1):111-3. PubMed ID: 2555198
[TBL] [Abstract][Full Text] [Related]
5. Effects of ergotamine on cardiovascular catecholamine receptors in the pithed rat.
Badia A; Moron A; Cuffi L; Vila E
Gen Pharmacol; 1988; 19(3):475-81. PubMed ID: 2843416
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment with chlorpromazine and haloperidol but not with sulpiride and clozapine markedly elevates neuropeptide Y-like immunoreactivity in the rat hypothalamus.
Obuchowicz E
Neuropeptides; 1996 Oct; 30(5):471-8. PubMed ID: 8923510
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular characterization of the DA2 dopamine receptor agonist quinpirole in rats.
Lefevre-Borg F; Lorrain J; Lechaire J; Thiry C; Lhoste F; Hicks PE; Cavero I
Fundam Clin Pharmacol; 1987; 1(3):179-200. PubMed ID: 2892767
[TBL] [Abstract][Full Text] [Related]
8. Effects of DA-1- and DA-2-dopamine antagonists on apomorphine-induced inhibition of peripheral sympathetic neurotransmission.
Hietala J
J Auton Pharmacol; 1988 Dec; 8(4):297-302. PubMed ID: 2855331
[TBL] [Abstract][Full Text] [Related]
9. Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity concentrations in the nucleus accumbens of rat.
Obuchowicz E; Turchan J
Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):51-9. PubMed ID: 10082228
[TBL] [Abstract][Full Text] [Related]
10. Presynaptic dopamine receptors in the pithed rat: characterization with apomorphine and comparison with central dopamine autoreceptors.
Hietala J; MacDonald E; Scheinin M
Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):291-7. PubMed ID: 3799208
[TBL] [Abstract][Full Text] [Related]
11. In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of action.
Cohen BM; Lipinski JF
Life Sci; 1986 Dec; 39(26):2571-80. PubMed ID: 2879204
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the hypotensive action of dopamine receptor agonists fenoldopam and quinpirole in anaesthetized rats.
Sengupta S; Lokhandwala MF
J Auton Pharmacol; 1985 Dec; 5(4):289-94. PubMed ID: 2869041
[TBL] [Abstract][Full Text] [Related]
13. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
Ogren SO; Hall H; Köhler C; Magnusson O; Lindbom LO; Angeby K; Florvall L
Eur J Pharmacol; 1984 Jul; 102(3-4):459-74. PubMed ID: 6149133
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the cardiovascular effects of haloperidol, thioridazine and chlorpromazine HCl.
Brannan MD; Riggs JJ; Hageman WE; Pruss TP
Arch Int Pharmacodyn Ther; 1980 Mar; 244(1):48-57. PubMed ID: 6251766
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of bromocriptine in rats: role of peripheral adrenergic and dopaminergic receptors.
Roquebert J; Alaoui K; Morán Benito A
J Auton Pharmacol; 1990 Apr; 10(2):85-96. PubMed ID: 2161850
[TBL] [Abstract][Full Text] [Related]
16. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
[TBL] [Abstract][Full Text] [Related]
17. Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations.
Costall B; Naylor RJ
Br J Pharmacol; 1995 Dec; 116(7):2989-99. PubMed ID: 8680734
[TBL] [Abstract][Full Text] [Related]
18. Atypical neuroleptics suppress dopaminergic behavioral supersensitivity.
Schremmer C; Morgenstern R; Fink H; Ott T
Psychopharmacology (Berl); 1990; 100(3):399-403. PubMed ID: 1969173
[TBL] [Abstract][Full Text] [Related]
19. Involvement of different dopamine receptors in rat diphasic motility response to apomorphine.
Vaccheri A; Dall'Olio R; Gandolfi O; Montanaro N
Psychopharmacology (Berl); 1986; 89(3):265-8. PubMed ID: 2873607
[TBL] [Abstract][Full Text] [Related]
20. B-HT 958 lowers blood pressure and heart rate in the rat through stimulation of dopamine receptors.
Brown MJ; Harland D
Br J Pharmacol; 1986 Feb; 87(2):361-70. PubMed ID: 3006858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
